Pulsed Laser Light and Nano-encapsulated Ocular Dyes for Advanced Therapies in the Eye Ghent University
Vision impairment is a major cause of disability. In Europe, an average of 1 in 30 people experience sight loss. Treatment of ocular diseases is a top priority today. However, the arsenal of medications remains rather restricted to traditional drugs despite improvements in pharmacological treatments. In this context, the EU-funded DYE-LIGHT project will explore new ways to deliver biotherapeutics and perform ocular surgery. Going beyond ...